Abstract:Human defensins form a family of small, cationic, and Cys-rich antimicrobial proteins that play important roles in innate immunity against invading microbes. They also function as effective immune modulators in adaptive immunity by selectively chemoattracting T lymphocytes and immature dendritic cells. On the basis of sequence homology and the connectivity of six conserved Cys residues, human clefensins are classified into alpha and beta families. Structures of several beta-defensins have recently been characterized, confirming the disulfide connectivity conserved within the family, i.e., Cys(1)-Cys(5), Cys(2)-Cys(4), and Cys(3)-Cys(6). We found that human beta-defensin 3 (hBD3), a recently described member of the growing beta family, did not fold preferentially into a native conformation in vitro under various oxidative conditions. Using the orthogonal protection of Cys(1)-Cys(5) and of Cys(1)-Cys(6), we chemically synthesized six topological analogs of hBD3 with predefined disulfide connectivities, including the (presumably) native beta pairing. Unexpectedly, all differently folded hBD3 species exhibited similar antimicrobial activity against Escherichia coli, whereas a wide range of chemotactic activities was observed with these analogs for monocytes and cells transfected by the chemokine receptor CCR6. Furthermore, whereas substitution of all Cys residues by alpha-aminobutyric acid completely abolished the chemotactic activity of hBD3, the bactericidal activity remained unaffected in the absence of any disulfide bridge. Our findings demonstrate that disulfide bonding in hBD3, although required for binding and activation of receptors for chemotaxis, is fully dispensable for its antimicrobial function, thus shedding light on the mechanisms of action for human beta-defensins and the design of novel peptide antibiotics.

Antimicrobial Characterization of Human -Defensin 3 Derivatives

Engineering Disulfide Bridges To Dissect Antimicrobial And Chemotactic Activities Of Human Beta-Defensin 3

Toward Understanding the Cationicity of Defensins

Recent advances in the research and development of human defensins.

[Advances in the Research of Human Defensins].

A Chimeric Cationic Peptide Composed of Human β-Defensin 3 and Human β-Defensin 4 Exhibits Improved Antibacterial Activity and Salt Resistance

Human Defensins: Synthesis and Structural Properties

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

173 Human Defensins - Small in Size but Big in Functionality

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Reconstruction of the Conserved Β-Bulge in Mammalian Defensins Using D-Amino Acids

Production of Bioactive Human β -defensin-3 in Escherichia coli by Soluble Fusion Expression

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Production Of Bioactive Human Beta-Defensin-3 In Escherichia Coli By Soluble Fusion Expression

Synthesis and characterization of human alpha-defensins 4-6.

α-Defensins in human innate immunity.

Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide

From Pro Defensins to Defensins: Synthesis and Characterization of Human Neutrophil Pro Alpha-Defensin-1 and Its Mature Domain.

Antibacterial Activity and Specificity of the Six Human Α-Defensins

Human alpha-defensin 5 variant and uses thereof